These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6656882)

  • 41. Colcemid treatment of myeloma prior to cell fusion increases the yield of hybridomas between myeloma and splenocyte.
    Miyahara M; Nakamura H; Hamaguchi Y
    Biochem Biophys Res Commun; 1984 Nov; 124(3):903-8. PubMed ID: 6508785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for somatic cell expression of the c-mos protein [corrected].
    Herzog NK; Ramagli LS; Khorana S; Arlinghaus RB
    Oncogene; 1989 Nov; 4(11):1307-15. PubMed ID: 2530484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas.
    Stanton LW; Watt R; Marcu KB
    Nature; 1983 Jun 2-8; 303(5916):401-6. PubMed ID: 6304522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin kappa gene but far from the myc oncogene.
    Webb E; Adams JM; Cory S
    Nature; 1984 Dec 20-1985 Jan 2; 312(5996):777-9. PubMed ID: 6440031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
    Seifert M; Jahn S; Schwab J; Döcke W; Volk HD; von Baehr R
    Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arrangement of lambda light chain genes in mutant clones of the MOPC 315 mouse myeloma cells.
    Hozumi N; Wu G; Murialdo H; Baumal R; Mosmann T; Winberry L; Marks A
    J Immunol; 1982 Jul; 129(1):260-6. PubMed ID: 6806362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The c-myc oncogene is translocated to the involved chromosome 12 in mouse plasmacytoma.
    Erikson J; Miller DA; Miller OJ; Abcarian PW; Skurla RM; Mushinski JF; Croce CM
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4212-6. PubMed ID: 3923490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of activation of the mouse c-mos oncogene by the LTR of an intracisternal A-particle gene.
    Horowitz M; Luria S; Rechavi G; Givol D
    EMBO J; 1984 Dec; 3(12):2937-41. PubMed ID: 6098457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unresponsiveness of both non-rearranged and rearranged c-myc to serum stimulation in a mouse plasmacytoma S194.
    Kondoh N; Oikawa T; Chiba I; Ogiso Y; Mizuno S; Kuzumaki N
    Leuk Res; 1987; 11(12):1149-56. PubMed ID: 2447448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors.
    Adams JM; Gerondakis S; Webb E; Mitchell J; Bernard O; Cory S
    Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6966-70. PubMed ID: 6294668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.
    Van Snick J; Vink A; Cayphas S; Uyttenhove C
    J Exp Med; 1987 Mar; 165(3):641-9. PubMed ID: 3493321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional activation of immunoglobulin alpha heavy-chain genes by translocation of the c-myc oncogene.
    Dean M; Kent RB; Sonenshein GE
    Nature; 1983 Sep 29-Oct 5; 305(5933):443-6. PubMed ID: 6413865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stable antibody-producing murine hybridomas.
    Taggart RT; Samloff IM
    Science; 1983 Mar; 219(4589):1228-30. PubMed ID: 6402815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of Ig gene expression by Ig binding factors. Suppression of alpha-H chain and lambda-2-L chain mRNA accumulation in MOPC-315 by IgA-binding factor.
    Roman S; Moore JS; Darby C; Müller S; Hoover RG
    J Immunol; 1988 May; 140(10):3622-30. PubMed ID: 3129498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production and characterization of a monoclonal antibody to the v-mos oncogene protein.
    Ishikawa K; Kurata N; Aoki H; Kato T; Marunouchi T
    Hybridoma; 1991 Jun; 10(3):357-68. PubMed ID: 1833309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modes of c-myc oncogene activation in murine plasmacytomas.
    Yang JQ; Mushinski JF; Stanton LW; Fahrlander PD; Tesser PC; Marcu KB
    Curr Top Microbiol Immunol; 1984; 113():146-53. PubMed ID: 6478862
    [No Abstract]   [Full Text] [Related]  

  • 58. Production of stable mouse x human hybridomas secreting HBs antigen-specific human monoclonal antibody by using in vitro sensitization.
    Maeda T; Eda Y; Nishiyama K; Ishikawa Y; Tashiro A; Watanabe T
    Hybridoma; 1986; 5(1):33-41. PubMed ID: 3957359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of c-mos proto-oncogene transcripts in mouse tissues.
    Propst F; Vande Woude GF
    Nature; 1985 Jun 6-12; 315(6019):516-8. PubMed ID: 4000280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas.
    Spieker-Polet H; Sethupathi P; Yam PC; Knight KL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9348-52. PubMed ID: 7568130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.